Pemetrexed versus Gefitinib versus Erlotinib in Previously Treated Patients with Non-Small Cell Lung Cancer

BACKGROUND/AIMS: The efficacy and safety of pemetrexed, gefitinib, and erlotinib administration in previously treated patients with non-small cell lung cancer (NSCLC) were compared. METHODS: The study patients met the following criteria: histologically confirmed, previously treated advanced (stage I...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Junshik, Kyung, Sun Young, Lee, Sang Pyo, Park, Jeong Woong, Jung, Sung Hwan, Lee, Jae-Ik, Park, Se Hoon, Sym, Sun Jin, Park, Jinny, Cho, Eun Kyung, Shin, Dong Bok, Lee, Jae Hoon
Formato: Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2932943/
https://www.ncbi.nlm.nih.gov/pubmed/20830227
http://dx.doi.org/10.3904/kjim.2010.25.3.294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2932943/
https://www.ncbi.nlm.nih.gov/pubmed/20830227
http://dx.doi.org/10.3904/kjim.2010.25.3.294

Ejemplares similares